Upcoming Webinar :Register now for 'ULIP as an investment during economic recovery' powered by Bajaj Allianz Life Insurance
you are here: HomeNewscoronavirus

Travel restrictions effective in countries with low number of COVID-19 cases: Lancet study

The study also suggests that travel restrictions may have been most effective during the early stages of the pandemic, and the measures are unlikely to be effective when the virus is already spreading rapidly within a country.

Dec 8, 2020 / 02:59 PM IST
(Image: Reuters)

(Image: Reuters)

Travel restrictions are effective in countries with low numbers of COVID-19 cases, or that have strong travel links with nations experiencing high rates of the viral infection, according to a study published in The Lancet Public Health journal.

The study also suggests that travel restrictions may have been most effective during the early stages of the pandemic, and the measures are unlikely to be effective when the virus is already spreading rapidly within a country.

"We recognise that these measures carry a high economic and social cost, so it is important that governments use travel restrictions in a targeted way," said Professor Mark Jit from the London School of Hygiene and Tropical Medicine, who led the study.

"Before introducing restrictions, they should take into account local infection figures, epidemic growth rates, and the volume of travellers arriving from countries heavily-affected by the virus," Jit explained.

Follow our LIVE blog for the latest updates of the novel coronavirus pandemic

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The researchers used detailed flight data to compare the number of expected COVID-19 cases arriving from international flights with the number of infections arising from transmission within individual countries.

They produced estimates of international travellers in May and September 2020 based on two scenarios.

One scenario used flight data for the same months in 2019, assuming no reduction in travel numbers, and the other scenario was based on the expected reduction in passenger numbers.

Numbers of COVID-19 cases and infection rates were estimated using a mathematical model that adjusts recorded cases to take account of asymptomatic and unreported infections.

Results were determined based on how imported COVID-19 cases would affect local epidemic growth rates, using country-specific reproduction number, or R number, estimates.

Where imported cases accounted for more than 10 per cent of infections within individual countries, they were considered to have a major impact on growth of the epidemic, the study found.

The work estimated that when imported cases accounted for less than 10 per cent, their impact on the growth of the epidemic is usually small, while those below 1 per cent would have an almost undetectable effect on epidemic size.

The researchers noted that had there been no travel restrictions or reduction in travel volumes in May 2020, the imported COVID-19 cases would account for more than 10 per cent of infections in the majority of countries included in the analysis, the researchers said.

Imported cases would account for no more than 10 per cent of infections in 34 out of 136 countries, and less than 1 per cent in four, they said.

According to the estimates based on expected passenger numbers in May 2020, imported cases would have contributed to more than 10 per cent of total incidence in 74 countries, less than 10 per cent of total incidence in 62 countries, and to less than 1 per cent in eight countries.

However, by September 2020, had there been no travel restrictions or reduction in travel volumes, imported cases would account for more than 10 per cent of infections in only a small number of countries.

Imported cases account for less than 10 per cent of infections in 106 out of 162 countries, and less than 1 per cent in 21, the researchers said.

According to the estimates based on expected passenger numbers in September 2020, travel restrictions would have contributed to more than 10 per cent of infections in only 37 countries, less than 10 per cent in 125 countries and less than 1 per cent in only 44 countries.

The findings indicate that international travel restrictions were most effective at limiting local transmission of the virus during earlier stages of the pandemic, said the researchers, adding this is because imported cases led to outbreaks in countries with very few or no existing cases.

Follow our full coverage of the coronavirus pandemic here.
PTI
first published: Dec 8, 2020 02:59 pm

stay updated

Get Daily News on your Browser
Sections